Education
About Us
Working with TipRanks
Follow Us
FNX - ETF AI Analysis
Top Page
First Trust Mid Cap Core AlphaDEX Fund (FNX)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as MP Materials and Bloom Energy, have delivered strong year-to-date gains, supporting the fund’s performance.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Financials, and Consumer Cyclical, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown positive year-to-date growth, indicating resilience in its portfolio despite recent market fluctuations.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with minimal exposure to international markets, limiting global diversification.
Underperforming Holdings
Some top holdings, such as Avantor and SoundHound AI, have struggled with negative year-to-date performance, which could weigh on overall returns.
Moderate Expense Ratio
The fund’s expense ratio is higher than some low-cost ETFs, which could reduce net returns for long-term investors.
FNX vs. SPDR S&P 500 ETF (SPY)
AUM1.16B
RegionNorth America
Expense Ratio0.60%
Beta0.97
IssuerFirst Trust
Inception DateMay 08, 2007
Dividend Yield0.93%
Asset ClassEquity
Index TrackedNASDAQ AlphaDEX Mid Cap Core Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,882
30 Day Avg. Volume15,384
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
145.11Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering450
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FNX Summary
The First Trust Mid Cap Core AlphaDEX Fund (FNX) is an ETF that focuses on mid-sized companies, offering a mix of growth and value opportunities. It tracks the NASDAQ AlphaDEX Mid Cap Core Index, using a rules-based approach to select stocks based on financial metrics like growth rates and return on assets. Some of its holdings include companies like Bloom Energy and Symbotic. Investors might consider FNX for diversification and the potential growth of mid-cap stocks, which are often more agile than large-cap companies. However, it’s important to note that mid-cap stocks can be more volatile than larger, established companies.
How much will it cost me?The expense ratio for FNX is 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average for ETFs because FNX uses an actively managed, rules-based stock selection process to target mid-cap companies with growth and value potential.
What would affect this ETF?The FNX ETF, with its focus on mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology, industrials, and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can negatively impact financial and real estate sectors, or economic slowdowns that could affect mid-cap companies more than larger, established firms. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings, such as those in energy or materials.
FNX Top 10 Holdings
The First Trust Mid Cap Core AlphaDEX Fund (FNX) leans heavily on U.S. mid-cap stocks, with a notable concentration in industrials, financials, and consumer cyclical sectors. Among its top holdings, Guardant Health and Lumentum Holdings are rising stars, showing strong technical momentum and earnings optimism, though both face valuation challenges. Meanwhile, Madrigal Pharmaceuticals offers a mixed bag, with promising growth offset by profitability struggles. On the downside, NEXTracker and Bunge Global are lagging slightly, grappling with tariff issues and macroeconomic uncertainties. Overall, FNX’s diverse sector exposure balances innovation with stability, making it a dynamic choice for mid-cap investors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lumentum Holdings | 0.73% | $8.66M | $23.24B | 253.90% | 61 Neutral | |
| Guardant Health | 0.63% | $7.47M | $14.04B | 192.43% | 58 Neutral | |
| Bloom Energy | 0.51% | $6.00M | $27.93B | 354.89% | 61 Neutral | |
| Hecla Mining Company | 0.51% | $5.98M | $11.27B | 196.65% | 75 Outperform | |
| Ciena | 0.49% | $5.78M | $27.61B | 170.98% | 74 Outperform | |
| Alcoa | 0.49% | $5.75M | $11.40B | -4.68% | 74 Outperform | |
| Madrigal Pharmaceuticals | 0.47% | $5.49M | $13.31B | 87.26% | 56 Neutral | |
| PTC Therapeutics | 0.46% | $5.45M | $6.25B | 60.85% | 73 Outperform | |
| TTM Technologies | 0.46% | $5.44M | $7.53B | 193.71% | 77 Outperform | |
| Mattel | 0.46% | $5.40M | $6.57B | 6.93% | 76 Outperform |
FNX Technical Analysis
Positive
―
Price Trends
124.31
Positive
122.66
Positive
116.14
Positive
Market Momentum
0.66
Negative
60.44
Neutral
92.35
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FNX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 122.99, equal to the 50-day MA of 124.31, and equal to the 200-day MA of 116.14, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 60.44 is Neutral, neither overbought nor oversold. The STOCH value of 92.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FNX.
FNX Peer Comparison
Comparison Results
Performance Comparison
FNX
First Trust Mid Cap Core AlphaDEX Fund
127.00
3.86
3.13%
XMHQ
Invesco S&P MidCap Quality ETF
―
―
―
XMMO
Invesco S&P MidCap Momentum ETF
―
―
―
JHMM
John Hancock Multifactor Mid Cap ETF
―
―
―
FMDE
Fidelity Enhanced Mid Cap ETF
―
―
―
DON
WisdomTree U.S. MidCap Dividend Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents